Charles River Laboratories Income Statement
CRL / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Charles River Laboratories reported $4.0B in revenue and $144M in net loss for FY2025. Revenue has grown at a 9.2% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.0B | $4.0B | $3.5B | $2.9B | $2.6B | $2.3B | $1.9B | $2.3B | $445.8M | $1.7B | $1.2B | $1.3B | $1.2B | $1.1B | $1.2B |
| Cost of Revenue | - | - | - | - | - | - | - | - | $289.7M | $277.0M | $272.8M | $266.4M | $272.8M | $257.7M | $255.7M |
| Gross Profit | - | - | - | - | - | - | $211.8M | $181.5M | $171.7M | $140.8M | $119.7M | $108.8M | - | - | - |
| SG&A Expense | $743.1M | $751.0M | $619.9M | $528.9M | $517.6M | $443.9M | $371.3M | $443.9M | $371.3M | $364.7M | $225.7M | $269.0M | $225.7M | $208.2M | $227.7M |
| Operating Income | $25.2M | $227.3M | $589.9M | $432.7M | $351.2M | $331.4M | $288.3M | $331.4M | $288.3M | $237.6M | $151.4M | $177.7M | $151.4M | $165.8M | $169.6M |
| Interest Expense | - | - | $73.9M | $86.4M | $60.9M | $63.8M | $29.8M | $63.8M | $29.8M | $27.7M | $21.0M | $11.9M | $21.0M | $33.3M | $21.7M |
| Income Tax | $42.7M | $67.8M | $81.9M | $81.8M | $50.0M | $54.5M | $171.4M | $54.5M | $171.4M | $66.8M | $32.9M | $47.7M | $32.9M | $27.6M | $40.4M |
| Net Income | -$144.3M | $22.2M | $391.0M | $364.3M | $252.0M | $226.4M | $123.4M | $226.4M | $123.4M | $154.8M | $102.8M | $126.7M | $102.8M | $97.9M | $112.6M |
| EPS (Basic) | -$2.91 | $9.57 | $7.77 | $7.35 | $5.17 | $4.72 | $2.60 | $3.29 | $3.21 | $2.72 | $2.15 | $2.03 | $2.16 | -$5.38 | $1.75 |
| EPS (Diluted) | -$2.91 | $9.48 | $7.60 | $7.20 | $5.07 | $4.62 | $2.54 | $3.23 | $3.13 | $2.66 | $2.12 | $2.01 | $2.14 | -$5.38 | $1.74 |
| Shares Outstanding | 49.2M | 51.3M | 50.9M | 50.5M | 49.8M | 48.9M | 48.2M | 47.4M | 47.4M | 46.7M | 47.3M | 47.6M | 51.3M | 62.6M | 56.4M |
| Gross Margin | - | - | - | - | - | - | 11.4% | 8.0% | 38.5% | 8.4% | 10.3% | 8.4% | - | - | - |
| Operating Margin | 0.6% | 5.6% | 16.7% | 14.8% | 13.4% | 14.6% | 15.5% | 14.6% | 64.7% | 14.1% | 13.0% | 13.7% | 13.0% | 14.7% | 14.5% |
| Profit Margin | -3.6% | 0.5% | 11.0% | 12.5% | 9.6% | 10.0% | 6.6% | 10.0% | 27.7% | 9.2% | 8.8% | 9.8% | 8.8% | 8.7% | 9.6% |